Lakefront Biotherapeutics NV (LKFT) stock
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
$33.98+0.05 (+0.15%)
Close on Nov 13, 2026Market cap $2.24BP/E 6.3Yield –
Lakefront Biotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 28.9%, against 26.9% the year before. The highest annual figure on record is 88.3% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.9% | +2.0 |
| FY2024 | Dec 31, 2024 | 26.9% | −61.4 |
| FY2023 | Dec 31, 2023 | 88.3% | +178.7 |
| FY2022 | Dec 31, 2022 | -90.4% | −46.3 |
| FY2021 | Dec 31, 2021 | -44.0% | +19.8 |
| FY2020 | Dec 31, 2020 | -63.9% | −81.8 |
| FY2019 | Dec 31, 2019 | 17.9% | +28.4 |
| FY2018 | Dec 31, 2018 | -10.5% | +80.5 |
| FY2017 | Dec 31, 2017 | -91.0% | −132.7 |
| FY2016 | Dec 31, 2016 | 41.7% | +341.0 |
| FY2015 | Dec 31, 2015 | -299.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | -46.0% | +86.3 |
| Q2 FY2020 | Jun 30, 2020 | -115.5% | – |
| Q2 FY2019 | Jun 30, 2019 | -80.4% | – |
| Q2 FY2018 | Jun 30, 2018 | -43.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -132.3% | – |
See a number that looks wrong?